Clinical Research Associates (CRAs) must adapt to the evolving demands of oncology therapeutics, which require specialized knowledge for effective trial monitoring. As oncology treatments become more complex, it is crucial for sponsors and CROs to provide enhanced training and support to ensure CRAs can effectively oversee these studies. This article emphasizes the importance of ongoing education and strategic hiring processes to ensure the highest quality monitoring.
